TY - DATA T1 - Method for detecting rheumatoid arthritis employing the CB10 peptide of mammalian type II collagen as an antigen PY - 2016/09/07 AU - Andrew Cook AU - Merrill Rowley AU - Ian Mckay AU - Montech Medical Developments Pty Ltd AU - Rondole Pty Ltd UR - https://bridges.monash.edu/articles/standard/Method_for_detecting_rheumatoid_arthritis_employing_the_CB10_peptide_of_mammalian_type_II_collagen_as_an_antigen/3810891 DO - 10.4225/03/57D0A6A652864 L4 - https://ndownloader.figshare.com/files/5934435 KW - Patents -- United States KW - United States -- Patents and Trademark Office KW - 2004 KW - Monash University Patents Collection KW - 1959.1/23509 KW - monash:2734 KW - 1959.1/2734 KW - US006706490B1 KW - WO98/41865 KW - eng N2 - A predictive test for rheumatoid arthritis comprises the detection of antibodies to collagen in a biological sample from a patient by contacting the biological sample with an antigen comprising the CB10 peptide of mammalian type II collagen, or an antibody-binding fragment or variant thereof, for a time and under conditions for an antibody-antigen complex to form, and detecting the antibody-antigen complex, for example by immunoassay. A diagnostic test kit is also disclosed. ER -